Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Valtech Provides Biotechnology and Technology Startup Orientated Valuation Support 2023-12-07 10:00
Innovent Biologics and Synaffix Expand ADC Collaboration Following Positive Preliminary Clinical Signal from Ongoing Phase 1 Study 2023-12-07 09:00
Positive Topline Results from Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer Presented at SABCS 2023-12-07 06:45
World Innovation Summit for Health Announces Dates for 2024 Event and Strategic Partnership with WHO 2023-12-07 03:00
LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches 2023-12-06 23:00
Micro Medical Solutions Announces Completion of Enrollment in the STAND Pivotal Clinical Trial 2023-12-06 21:32
SaniSure earns EcoVadis Silver Rating, recognizing strong commitment to sustainability 2023-12-06 20:30
Antengene Announces XPOVIO® Regulatory Approval in Macau for the Treatment of Relapsed and/or Refractory Multiple Myeloma 2023-12-06 17:00
Qilu Pharmaceutical Announces Results from Phase II Study for iparomlimab for Advanced Solid Tumors at ESMO Asia, with an ORR of 45.8% 2023-12-06 16:55
Koselugo now available in Malaysia for paediatric patients with symptomatic neurofibromatosis type 1 (NF1) plexiform neurofibromas 2023-12-06 16:46
The Grand Opening of River Cam Dermatology Centre and River Cam Nutrition Center (Shatin) Amalgamates Ancient Chinese Medicine Skin Care Wisdom and Nutrition Science 2023-12-06 10:43
Innovent Announces the Phase 3 ORIENT-16 Study Results Published in JAMA Evaluating Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma 2023-12-06 08:16
Sirnaomics Announces Successful Completion of Cohort 1 from Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Treatment 2023-12-06 01:01
Merck Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis 2023-12-05 21:00
Ascletis Announces Initiation of Phase III Clinical Trial of ASC40 (Denifanstat) for Treatment of Acne 2023-12-05 16:50
Clarivate Expands Partnership with VeriSIM Life to Accelerate and De-risk Research and Drug Development 2023-12-05 15:00
Insilico Medicine Announces First-in-Human Study for Orally PHD Inhibitor ISM5411 for Inflammatory Bowel Disease (IBD) 2023-12-05 06:00
Latest Updates of Viva's Portfolio Companies 2023-12-04 17:55
Supercell Acquires Exclusive Licensing from Japanese Immunotherapy Leader for Advanced NK Cell Treatment Technology 2023-12-04 16:39
First Patient Dosed in Phase Ⅲ Study of JSKN003 for the Treatment of Advanced HER2-Low Breast Cancer 2023-12-04 14:51
1 65 66 67 68 69 531